Core Viewpoint - Huajian Medical (1931.HK) has experienced a significant stock price increase, reaching a historical high, driven by its strategic move into the global enhanced Ethereum treasury market [1] Group 1: Stock Performance - The stock price of Huajian Medical surged nearly 27% to 9.95 HKD, marking a new historical high [1] - The stock has seen a cumulative increase of 120% in July, with prices doubling again in August [1] Group 2: Strategic Initiatives - Huajian Medical has officially launched a strategy for a "global enhanced Ethereum treasury" with a focus on Ethereum as a core reserve asset [1] - The company aims to become a leading listed company in terms of Ethereum reserve scale in the Hong Kong market and globally [1] - Funding for this strategy will come from various sources, including self-owned funds, stable annual distributable profits, replacement of inefficient inventory assets, and continuous financing through ATM (At-The-Market) [1] Group 3: Partnerships and Collaborations - The company has signed a global strategic cooperation framework agreement with HashKey Group, a leading digital asset financial services group [1] - This partnership aims to accelerate the implementation of the "global enhanced Ethereum treasury" strategy and provide efficient, secure, and compliant digital asset services to global clients [1] Group 4: Cryptocurrency Market Context - The cryptocurrency market has shown strength, with Bitcoin surpassing 12.1 thousand USD per coin and Ethereum breaking through 4300 USD per coin, reaching a new high since the end of 2021 [1]